USD 5.99
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 135.58 Million EUR | -0.06% |
2022 | 135.65 Million EUR | -0.26% |
2021 | 136 Million EUR | 370.13% |
2020 | 28.92 Million EUR | -6.17% |
2019 | 30.83 Million EUR | 3.56% |
2018 | 29.77 Million EUR | -7.88% |
2017 | 32.31 Million EUR | 63.45% |
2016 | 19.77 Million EUR | -1.26% |
2015 | 20.02 Million EUR | 34.44% |
2014 | 14.89 Million EUR | 3.91% |
2013 | 14.33 Million EUR | -11.14% |
2012 | 16.13 Million EUR | 9.52% |
2011 | 14.73 Million EUR | -17.56% |
2010 | 17.87 Million EUR | 45.56% |
2009 | 12.27 Million EUR | 0.61% |
2008 | 12.2 Million EUR | -2.61% |
2007 | 12.53 Million EUR | -2.68% |
2006 | 12.87 Million EUR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 132.45 Million EUR | -2.31% |
2024 Q2 | 134.89 Million EUR | 2.36% |
2023 Q2 | 141.53 Million EUR | 2.73% |
2023 FY | 135.58 Million EUR | -0.06% |
2023 Q3 | 138.16 Million EUR | -2.38% |
2023 Q1 | 137.77 Million EUR | 1.56% |
2023 Q4 | 135.58 Million EUR | -1.87% |
2022 Q3 | 137.75 Million EUR | 0.0% |
2022 Q4 | 135.65 Million EUR | -1.52% |
2022 FY | 135.65 Million EUR | -0.26% |
2022 Q1 | 136.11 Million EUR | 0.08% |
2022 Q2 | 137.74 Million EUR | 1.2% |
2021 FY | 136 Million EUR | 370.13% |
2021 Q1 | 29.44 Million EUR | 1.77% |
2021 Q2 | 29.71 Million EUR | 0.94% |
2021 Q3 | 28.19 Million EUR | -5.12% |
2021 Q4 | 136 Million EUR | 382.36% |
2020 FY | 28.92 Million EUR | -6.17% |
2020 Q2 | 29.82 Million EUR | -1.4% |
2020 Q3 | 29.31 Million EUR | -1.74% |
2020 Q4 | 28.92 Million EUR | -1.3% |
2020 Q1 | 30.25 Million EUR | -1.88% |
2019 Q2 | 30.15 Million EUR | -1.37% |
2019 Q3 | 29.97 Million EUR | -0.59% |
2019 Q4 | 30.83 Million EUR | 2.86% |
2019 FY | 30.83 Million EUR | 3.56% |
2019 Q1 | 30.57 Million EUR | 2.7% |
2018 Q1 | 32.12 Million EUR | -0.61% |
2018 Q4 | 29.77 Million EUR | -4.64% |
2018 Q3 | 31.21 Million EUR | 0.7% |
2018 Q2 | 31 Million EUR | -3.49% |
2018 FY | 29.77 Million EUR | -7.88% |
2017 Q2 | 40.41 Million EUR | 107.39% |
2017 Q3 | 39.86 Million EUR | -1.37% |
2017 FY | 32.31 Million EUR | 63.45% |
2017 Q4 | 32.31 Million EUR | -18.92% |
2017 Q1 | 19.48 Million EUR | -1.45% |
2016 FY | 19.77 Million EUR | -1.26% |
2016 Q4 | 19.77 Million EUR | -0.48% |
2016 Q3 | 19.86 Million EUR | 3.16% |
2016 Q2 | 19.26 Million EUR | -2.84% |
2016 Q1 | 19.82 Million EUR | -1.0% |
2015 FY | 20.02 Million EUR | 34.44% |
2015 Q4 | 20.02 Million EUR | -2.75% |
2015 Q2 | 15.78 Million EUR | 1.32% |
2015 Q3 | 20.59 Million EUR | 30.49% |
2015 Q1 | 15.57 Million EUR | 4.56% |
2014 Q1 | 14.08 Million EUR | -1.72% |
2014 Q4 | 14.89 Million EUR | -0.11% |
2014 FY | 14.89 Million EUR | 3.91% |
2014 Q3 | 14.91 Million EUR | 6.78% |
2014 Q2 | 13.96 Million EUR | -0.87% |
2013 Q3 | 14.32 Million EUR | -1.04% |
2013 FY | 14.33 Million EUR | -11.14% |
2013 Q4 | 14.33 Million EUR | 0.06% |
2013 Q2 | 14.47 Million EUR | -3.2% |
2013 Q1 | 14.95 Million EUR | -7.31% |
2012 Q4 | 16.13 Million EUR | 3.3% |
2012 Q1 | 14.1 Million EUR | -4.23% |
2012 Q2 | 14.71 Million EUR | 4.32% |
2012 Q3 | 15.61 Million EUR | 6.12% |
2012 FY | 16.13 Million EUR | 9.52% |
2011 Q1 | 14.95 Million EUR | -16.3% |
2011 FY | 14.73 Million EUR | -17.56% |
2011 Q2 | 15.18 Million EUR | 1.54% |
2011 Q3 | 14.23 Million EUR | -6.26% |
2011 Q4 | 14.73 Million EUR | 3.48% |
2010 FY | 17.87 Million EUR | 45.56% |
2010 Q4 | 17.87 Million EUR | -1.94% |
2010 Q3 | 18.22 Million EUR | 2.26% |
2010 Q2 | 17.82 Million EUR | 64.02% |
2010 Q1 | 10.86 Million EUR | -11.49% |
2009 Q4 | 12.27 Million EUR | 0.0% |
2009 Q2 | 11.42 Million EUR | 0.0% |
2009 FY | 12.27 Million EUR | 0.61% |
2008 FY | 12.2 Million EUR | -2.61% |
2007 FY | 12.53 Million EUR | -2.68% |
2006 FY | 12.87 Million EUR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
The Amacore Group, Inc. | 24.7 Million USD | -448.697% |
Arem Pacific Corporation | 304.9 Thousand USD | -44366.929% |
Assisted 4 Living, Inc. | 184.16 Thousand USD | -73518.509% |
BioCorRx Inc. | 10.34 Million USD | -1211.049% |
Bionik Laboratories Corp. | 5 Million USD | -2610.148% |
Banyan Corp. | 4.51 Million USD | -2900.619% |
Clearday, Inc. | 65.13 Million USD | -108.163% |
Dental Patient Care America, Inc. | 1.8 Million USD | -7423.496% |
Quantum Medical Transport, Inc. | 1504.02 USD | -9014474.274% |
Empower Clinics Inc. | 9.18 Million USD | -1375.994% |
First Choice Healthcare Solutions, Inc. | 31.65 Million USD | -328.332% |
Selectis Health, Inc. | 43.63 Million USD | -210.714% |
Ethema Health Corporation | 17.71 Million USD | -665.153% |
HealthLynked Corp. | 3.47 Million USD | -3801.151% |
HQDA Elderly Life Network Corp. | - USD | -Infinity% |
Healthcare Solutions Management Group, Inc. | 14.47 Million USD | -836.672% |
JRSIS Health Care Corporation | 2.3 Million USD | -5781.587% |
Comjoyful International Company | 6.32 Million USD | -2043.202% |
Medical Facilities Corporation | 235.37 Million USD | 42.397% |
MedSmart Group Inc. | 927.53 Thousand USD | -14517.409% |
North America Frac Sand, Inc. | 936.85 Thousand USD | -14372.007% |
Nova Leap Health Corp. | 2.69 Million USD | -4923.461% |
Nexteligent Holdings, Inc. | 2.88 Million USD | -4604.19% |
PAO Group, Inc. | 1.04 Million USD | -12854.894% |
Primemd Inc. | 7.98 Million USD | -1597.161% |
Raffles Medical Group Ltd | 367.04 Million USD | 63.062% |
Ryman Healthcare Limited | 5.17 Billion USD | 97.383% |
Stem Cell Authority, Ltd. | 80.52 Thousand USD | -168271.313% |
SETO Holdings, Inc. | - USD | -Infinity% |
Optima Medical Innovations Corp. | 3.91 Million USD | -3362.392% |
Mycotopia Therapies, Inc. | 4.24 Million USD | -3091.851% |
U.S. NeuroSurgical Holdings, Inc. | 676 Thousand USD | -19956.361% |
Veltex Corporation | 2.87 Million USD | -4612.193% |
World Financial Holding Group | 132.5 Thousand USD | -102221.422% |
Xcelerate Inc. | 2.07 Million USD | -6432.23% |